Vanda Pharmaceuticals announces the publication of an article on The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial in the Clinical Gastroenterology and Hepatology Journal

WASHINGTON, Jan. 25, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. today announced the publication of an article titled The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic...

Related Keywords

Washington ,United States ,Eli Lilly ,Kevin Moran ,Drug Administration ,Vanda Pharmaceuticals Inc ,Prnewswire Vanda Pharmaceuticals Inc ,Idiopathic Gastroparesis ,Placebo Controlled Clinical ,Clinical Gastroenterology ,New Drug Application ,Prescription Drug User Fee Act ,Patients With Diabetic ,Vice President ,Chief Financial Officer ,Markets ,